Please provide your email address to receive an email when new articles are posted on . At 52 weeks, MASH resolution without worsening of fibrosis was reported among 36% on denifanstat vs. 13% on ...
Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial From a cohort of 303 ...
Study to improve histology interpretation of cirrhotic liver biopsies highlights limitations of current histology techniques and re-emphasizes the clinical relevance and regulatory potential of ...
AI-based digital pathology analysis provides high-resolution quantification of hepatic fibrosis and objective measurement of fibrosis ...
Post-hoc analyses corroborate previously reported antifibrotic effects of efruxifermin observed in 96-week Phase 2b SYMMETRY trial and indicate ...
Semaglutide significantly improved liver fibrosis and steatohepatitis resolution in MASH patients over 72 weeks compared to placebo. The study involved 800 patients receiving semaglutide and 400 ...
Zdenek Hel, Ph.D., a professor in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, received a five-year, $3.6 million R01 to support his project, “Dysregulated ...
The disconnect between research priorities of hepatologists, exercise professionals, and people with MASLD highlights the critical importance of community and consumer involvement throughout all ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback